[go: up one dir, main page]

ECSP13012914A - Síntesis de derivados de 2-carboxamida-cicloamino-urea - Google Patents

Síntesis de derivados de 2-carboxamida-cicloamino-urea

Info

Publication number
ECSP13012914A
ECSP13012914A ECSP13012914A ECSP13012914A EC SP13012914 A ECSP13012914 A EC SP13012914A EC SP13012914 A ECSP13012914 A EC SP13012914A EC SP13012914 A ECSP13012914 A EC SP13012914A
Authority
EC
Ecuador
Prior art keywords
urea
derivatives
cicloamino
carboxamida
synthesis
Prior art date
Application number
Other languages
English (en)
Inventor
Isabelle Sylvie Gallou
Florian Karl Kleinbeck
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP13012914(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP13012914A publication Critical patent/ECSP13012914A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

En la presente se proporcionan procesos y compuestos intermediarios útiles para la preparación de los derivados de 2-carboxamida-cicloamino-urea de la fórmula (X), y de los intermediarios útiles para los mismos.
ECSP13012914 2011-03-03 2013-10-02 Síntesis de derivados de 2-carboxamida-cicloamino-urea ECSP13012914A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03

Publications (1)

Publication Number Publication Date
ECSP13012914A true ECSP13012914A (es) 2013-11-29

Family

ID=45787206

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012914 ECSP13012914A (es) 2011-03-03 2013-10-02 Síntesis de derivados de 2-carboxamida-cicloamino-urea

Country Status (33)

Country Link
US (3) US9650373B2 (es)
EP (1) EP2681192B1 (es)
JP (1) JP6022485B2 (es)
KR (1) KR101851421B1 (es)
CN (2) CN103402982B (es)
AR (2) AR088714A1 (es)
AU (1) AU2012222346B2 (es)
BR (1) BR112013021882A2 (es)
CA (1) CA2828509C (es)
CL (1) CL2013002521A1 (es)
CO (1) CO6751286A2 (es)
DK (1) DK2681192T3 (es)
EA (4) EA201691331A1 (es)
EC (1) ECSP13012914A (es)
ES (1) ES2663717T3 (es)
GT (1) GT201300211A (es)
HU (1) HUE036319T2 (es)
IL (1) IL228023A (es)
MA (1) MA34982B1 (es)
MX (2) MX351740B (es)
MY (1) MY163214A (es)
NO (1) NO2681192T3 (es)
PE (1) PE20140917A1 (es)
PH (1) PH12013501796A1 (es)
PL (1) PL2681192T3 (es)
PT (1) PT2681192T (es)
SG (1) SG192793A1 (es)
SI (1) SI2681192T1 (es)
TN (1) TN2013000354A1 (es)
TW (2) TWI607994B (es)
UA (1) UA112539C2 (es)
WO (1) WO2012117071A1 (es)
ZA (1) ZA201306174B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
HK1244265A1 (zh) * 2014-11-14 2018-09-14 Gemphire Therapeutics Inc. 用於制备 -二羧酸封端的二烷醚的方法和中间体
WO2018195163A1 (en) 2017-04-18 2018-10-25 Gemphire Therapeutics Inc. Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
ATE309241T1 (de) 1999-09-10 2005-11-15 Merck & Co Inc Tyrosin kinase inhibitoren
AR044519A1 (es) * 2003-05-02 2005-09-14 Novartis Ag Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
TWI444370B (zh) * 2006-01-25 2014-07-11 Synta Pharmaceuticals Corp 用於發炎及免疫相關用途之噻唑及噻二唑化合物
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
UY31545A1 (es) 2007-12-20 2009-08-03 Nuevos derivados de 2-carboxamida cianoaminourea, sus sales y profarmacos farmacéuticamente aceptables, procesos de preparacion y aplicaciones
ATE517527T1 (de) * 2007-12-21 2011-08-15 Ericsson Telefon Ab L M Verfahren, vorrichtung und computerprogramm zum handover von einem ersten zugangspunkt an einen zweiten zugangspunkt
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
JP6022485B2 (ja) 2016-11-09
AR088714A1 (es) 2014-07-02
EA201792068A3 (ru) 2018-05-31
BR112013021882A2 (pt) 2016-07-19
KR20140009432A (ko) 2014-01-22
PH12013501796A1 (en) 2022-10-26
TW201722916A (zh) 2017-07-01
DK2681192T3 (en) 2018-04-16
EA201892052A1 (ru) 2019-02-28
US9650373B2 (en) 2017-05-16
IL228023A0 (en) 2013-09-30
EA201691331A1 (ru) 2017-01-30
TWI607994B (zh) 2017-12-11
KR101851421B1 (ko) 2018-04-23
NO2681192T3 (es) 2018-05-26
AR123584A2 (es) 2022-12-21
AU2012222346A1 (en) 2013-08-29
US20170355677A1 (en) 2017-12-14
ZA201306174B (en) 2014-05-28
WO2012117071A1 (en) 2012-09-07
EP2681192B1 (en) 2017-12-27
US20170240509A1 (en) 2017-08-24
TWI597279B (zh) 2017-09-01
IL228023A (en) 2017-04-30
PE20140917A1 (es) 2014-08-14
EP2681192A1 (en) 2014-01-08
MA34982B1 (fr) 2014-03-01
EA201391267A1 (ru) 2014-01-30
US9776966B2 (en) 2017-10-03
US10059670B2 (en) 2018-08-28
CA2828509A1 (en) 2012-09-07
CO6751286A2 (es) 2013-09-16
PL2681192T3 (pl) 2018-06-29
PT2681192T (pt) 2018-04-02
CN103402982B (zh) 2016-07-13
EA025381B1 (ru) 2016-12-30
TW201247660A (en) 2012-12-01
MY163214A (en) 2017-08-30
CA2828509C (en) 2018-11-20
GT201300211A (es) 2014-12-30
CN103402982A (zh) 2013-11-20
EA032802B1 (ru) 2019-07-31
ES2663717T3 (es) 2018-04-16
CN106083840B (zh) 2020-01-03
MX351740B (es) 2017-10-26
SI2681192T1 (en) 2018-04-30
SG192793A1 (en) 2013-09-30
HUE036319T2 (hu) 2018-06-28
US20130331579A1 (en) 2013-12-12
MX347348B (es) 2017-04-17
NZ614173A (en) 2015-04-24
EA201792068A2 (ru) 2018-01-31
TN2013000354A1 (en) 2015-01-20
CN106083840A (zh) 2016-11-09
AU2012222346B2 (en) 2015-05-07
MX2013010132A (es) 2013-10-30
CL2013002521A1 (es) 2014-02-14
JP2014511387A (ja) 2014-05-15
UA112539C2 (uk) 2016-09-26

Similar Documents

Publication Publication Date Title
ECSP14013251A (es) Derivados de 5-flúor-4-imino-3-(sustituido)-3,4-dihidropirimidin-2(1h)ona
CR20140464A (es) Compuestos de heterociclilo
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
ECSP12011581A (es) Inhibidores de bace
MX338078B (es) Cristales de anticuerpos anti-esclerostina y formulaciones de los mismos.
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
UY34472A (es) Derivados modificados de 4-fenil-piridina
CR20110370A (es) Derivados de sulfonamida
CR11776A (es) Inhibidores de bace
CR20130539A (es) Triazolopiridinas
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
UY34523A (es) Derivados de betulina
DOP2014000036A (es) Compuestos de piridazinona y su uso como inhibidores daao
ECSP11011485A (es) Espiro-epóxidos como productos intermedios.
CR20150061A (es) Compuesto de pirazolopirimidinas
CR20140435A (es) Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
CL2012000278A1 (es) Proceso para la obtencion de derivados de 5-trifluorometil-pirimidinas; y uno de los compuestos intermediarios considerados.
UY33976A (es) Derivados de pirazolo-pirimidina.
CR20140124A (es) Metabolitos de transclomifeno y usos de los mismos
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
UY34023A (es) Derivados de fenil-isoxazol y procedimiento para la preparación de los mismos
DOP2015000007A (es) Métodos para preparar triazolopiridinas sutituidas
CU20150015A7 (es) Tris-(hetero)aril-pirazoles y su uso
BR112015009720A2 (pt) método para a preparação de um composto de fórmula (i) e intermediários de síntese.
CR20150160A (es) Derivados de macrólidos, su preparación y su uso terapéutico